Top news of the week: 08.03.2022.
Healthcare
Novavax’s Covid-19 Vaccine Moves Closer to FDA Authorization Decision
The company says it has resolved the manufacturing problems that led to earlier delays, and the FDA is reviewing the shot’s authorization application.
Biotech Takes a Stand
Not long ago, biotech leaders steered clear of commenting on the issues of the day. Politics was limited to certain vested interests like drug pricing, science funding, and FDA regulation. ...
After 16 years, BMS' megablockbuster cancer drug finally runs into its first generic competition
First approved by the FDA in 2006, Bristol Myers Squibb's cash cow cancer drug Revlimid on Monday began seeing competition for the first time with a Teva generic. Acquired as part of BMS' ...
On The 5 Leadership Lessons She Learned From Her Experience
An Interview With Candice Georgiadis
Co. to Rebound After Q4/21 Sales Down Due to Virus Surge Research Report
The 2022 outlook for Outperform-rated company is positive given its focus on dermatology and implementing new commercial strategies, noted a report.
STAT announces second annual Breakthrough Science Summit
2022 STAT Breakthrough Science Summit will feature speakers from Bristol Myers Squibb, Pfizer, Merck Research Laboratories, and more, who will explore
EU startups starting to break through with a bit of help
Many entrepreneurs have experienced Aha! moments, which can strike at any time. For Dr Jama Nateqi, it was a clinical problem-solving assignment during his third year of medical school.
Midlands Engine at Leeds Life Innovation and Investor Showcase
Today [3 March], Midlands Engine Health is pleased to attend the Leeds Life Science Innovation and Investor Showcase. Organised by Northern Health Science Alliance (NHSA) and MedCity, the ...